Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17.
Sources familiar with the matter told The New York Times that the U.S. Food and Drug Administration could give the green light in about a week, which would make the Pfizer booster shot the first one available for people younger than 18.
When asked about plans to expand booster access, a Pfizer spokeswoman told the Times an update would be provided when available.
